This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
2/26/2025
Good morning and welcome to the earnings conference call for the period ended December 31, 2024, for MidCap Financial Investment Corporation. At this time, all participants have been placed in a listen-only mode. The call will be open for a question and answer session following the speaker's prepared remarks. If you would like to ask a question at that time, simply press star and 1 on your telephone keypad. If you would like to remove your question, you may press star and 2. I will now turn the call over to Elizabeth Besen, Investor Relations Manager for MidCap Financial Investment Corporation.
Thank you, operator, and thank you, everyone, for joining us today. We appreciate your interest in MidCap Financial Investment Corporation. Speaking on today's call are Tanner Powell, Chief Executive Officer, Ted McNulty, President, and Greg Hunt, Chief Financial Officer. Howard Widra, Executive Chairman, is on the call and available for the Q&A portion of today's call. I'd like to advise everyone that today's call and webcast are being recorded. Please note that they are the property of MidCap Financial Investment Corporation and that any unauthorized broadcast in any form is strictly prohibited. Information about the audio replay of this call is available in our press release. I'd also like to call your attention to the customary Safe Harbor disclosure in our press release regarding forward-looking information. Today's conference call and webcast may include forward-looking statements. You should refer to our most recent filings with the SEC for risks that apply to our business and that may adversely affect any forward-looking statements we make. We do not undertake to update our forward-looking statements or projections unless required by law. To obtain copies of our SEC filings, please visit either the SEC's website at .sec.gov or our website at .midcapfinancialic.com. I'd also like to remind everyone that we've posted a supplemental financial information package on our website which contains information about the portfolio as well as the company's financial performance. Throughout today's call, we will refer to MidCap Financial Investment Corporation as either MFIC or the BDC and we will use MidCap Financial to refer to the lender headquartered in Bequest of Maryland. At this time, I'd like to turn the call over to Tanner Powell, MFIC's Chief Executive Officer.
Thank you, Elizabeth. Good morning, everyone, and thank you for joining us for MFIC's fourth quarter earnings conference call. I'll begin today's call by providing an overview of MFIC's fourth quarter results and share our perspective on the current market environment. I will then turn the call over to Ted, who will discuss our investment activity and provide an update on the investment portfolio. Greg will then review our financial results and capital position in more detail. Beginning with our results, yesterday after market closed, we reported net investment income or NII per share of 40 cents for the December quarter and $1.71 for the full year. These results correspond to annualized return on equity or ROE of 10.5 percent for the quarter and 11.2 percent for the year. Gap net income per share was 26 cents for the December quarter and $1.27 for the full year. The vast majority of our portfolio is performing well and we are observing stability in certain credit metrics. NAV per share was $14.98 at the end of December, down 12 cents or approximately 0.8 percent. During the December quarter, we made $255 million of new commitments and for the full year, we made $1.06 billion of new commitments. While our market remains competitive, we observed a modest increase in spreads on our new commitments compared to the previous quarter, driven by commitments to existing borrowers at what we believe to be attractive leverage entry points. Spread compression in the core middle market has been less intense than what we see in the upper middle market. We have a clear and straightforward plan to gradually grow the portfolio over the coming quarters and we believe MFIC's future results are well positioned to benefit as we relever back to our target level. We expect to be able to reach our target leverage of approximately 1.4 times in the next couple of quarters. Taking a step back, as a reminder, in July, MFIC completed its mergers with Apollo Senior Floating Rate Fund and Apollo Tactical Income Fund, or the CEFs. We took advantage of strength in the liquid credit markets during the quarter and continued to sell certain assets acquired through the mergers that do not align with our strategy and prudently deployed the proceeds along with the investment capacity generated from the mergers into first lane floating rate middle market loans originated by MidCap Financial. Our affiliation with MidCap, a leading lender in the middle market, provides a significant deal sourcing advantage. We are fortunate to have access to the necessary origination to deploy this capital given the significant volume of commitments originated by MidCap Financial. In 2024, MidCap closed over 21.3 billion of commitments, including 6.6 billion in the fourth quarter. MidCap's origination volumes for the quarter and the full year are particularly notable given the overall muted sponsor M&A activity in the market. MidCap has what we believe to be one of the largest direct lending teams in the U.S. with close to 200 investment professionals. MidCap Financial was founded in 2009, has a long track record, which includes closing on approximately 130 billion of lending commitments since 2013. This origination track record provides us with a vast data set of middle market company financial information across all industries and we believe makes MidCap Financial one of the most informed and experienced middle market lenders in the market. We believe the core middle market offers attractive investment opportunities across cycles and does not complete compete directly with either the broadly syndicated loan or high yield market. As Greg will discuss in more detail, we continue to optimize MFIC's capital structure, including the closing of our second CLO post quarter end, which we believe strengthens our balance sheet and aligns with our investment strategy. Moving to Merck's, as discussed previously, we are focused on reducing our investment in our aircraft leasing and servicing business. I'd like to provide an update on Merck's Russia fleet insurance claims. As a reminder, at the time of Russia's invasion of Ukraine in February 2022 and the imposition of sanctions, Merck's own portfolio included four aircraft on lease to two Russian airlines. Those aircraft are held in aircraft securitization known as MAP-19. In compliance with the EU sanctions imposed on Russia due to the invasion, Merck's terminated the leases of those aircraft, but three were not returned and have remained in Russia since then. Merck's has brought legal action in the English courts seeking payment for those aircraft under both the lessee reinsurance policies and its own contingent policy. And we are pleased to announce that during the first quarter, we settled a portion of our contingent insurance claims with certain insurers. As mentioned on last quarter's call, we believe the current environment for selling aircraft is very attractive. Merck's has made substantial progress on multiple sales campaigns covering a majority of the remaining aircraft on its balance sheet. We look forward to providing further updates on the process as purchase agreements are finalized in the coming months. At the end of December, MFIC's investment in Merck's totaled approximately $183 million, representing 6.1 percent of the total portfolio at fair value. The blended yield across our total investment in Merck's was approximately 3.2 percent at fair value. And the continued rotation of capital from Merck's into directly originated corporate loans should have a beneficial impact on MFIC's income. Assuming we are successful with our sales campaign, we expect MFIC's exposure to Merck's to decline in the coming quarters. Moving to the economic environment, we entered 2025 with a solid economic backdrop underpinned by strong consumer spending, strong capital goods spending on infrastructure and AI, and a significant run up in stock prices. However, investors are increasingly focused on the near-term impact of tariffs and federal government layoffs. The spread's decision to increase their long-term dot implies that they are coming around to the view that interest rates will be permanently higher. Credit spreads have remained tight despite economic policy uncertainty rising. The probability of a recession has declined significantly over the past months and remains low for 2025. Specific to the direct lending market, we are seeing encouraging signs for an increase in sponsor-related M&A activity, including a strong economy, mounting pressure on financial sponsors to return capital, a potentially more favorable regulatory environment, and the stabilization of interest rates. As you know, private debt has become an increasingly important source of financing for sponsor transactions, especially in the middle market where we are focused. We are currently observing a notable increase in the number of deal screenings and indicating a pickup in activity. Repricing activity has continued at record levels with refinances and extensions continuing to increase as sponsors seek to address vintage investments in upcoming insurance. Prior to our dividend on February 21st, 2025, our board declared a quarterly dividend of 38 cents per share for shareholders of record as of March 11th, 2025, payable March 27th, 2025. With that, I will now turn the call over to Ted.
Thank you, Tanner. Good morning, everyone. I'm going to spend a few minutes reviewing our fourth quarter investment activity and then provide some details in our investment portfolio. In the December quarter, we continued to prudently deploy the capital acquired from the mergers. MFIC's new commitments in the December quarter totaled $255 million. As we've emphasized before, we intend to deploy this capital in a steady and measured manner, maintaining discipline in terms of obligor and vintage exposure. We are fortunate to have access to the necessary origination to deploy this capital, given the significant volume of commitments originated by MidCap Financial. As Tanner mentioned, MidCap Financial closed approximately $6.6 billion of new commitments during the December quarter. We believe it is prudent to gradually grow the portfolio in order to maintain our desired level of diversification. Despite significant competition for new deals, we observed a modest increase in spreads on new commitments compared to the previous quarter, driven by commitments to existing borrowers and what we believe to be attractive leverage entry points. The weighted average spread on new commitments in the December quarter was 546 basis points, up 13 basis points compared to commitments made in the December quarter, while the net leverage on new commitments decreased to 4.3 times in the December quarter, down from 4.7 times in the September quarter. We believe this attractive risk return profile reflects MidCap Financial's strong presence as a lender in the middle market and the power of incumbency. For the quarter, gross fundings totaled $248 million, excluding revolvers. Sales and repayments, excluding revolvers, totaled $254 million, including $96 million of assets acquired from the mergers. Net revolver repayments were less than $1 million. In total, net repayments for the quarter were $6 million. In the current quarter, we have continued to make progress selling assets acquired from the mergers. Turning to our investment portfolio, at the end of December, our portfolio had a fair value of $3.01 billion and was invested in 233 companies across 25 different industries. Direct origination and other, including the directly originated loans acquired from the CEFs, represented 90 percent of the total portfolio, up from 88 percent last quarter. The non-directly originated loans acquired from the CEFs, which includes high-yield bonds, broadly syndicated loans, and structured credit positions, represented 4 percent, down from 6 percent. As you can see on page six of the earnings supplement, we break out the non-directly originated assets that we acquired from the mergers. Lastly, Merck's accounted for approximately 6 percent of the total portfolio. All of these figures are on a fair value basis. Specific to the direct origination portfolio, at the end of December, 98 percent was first to lean, and 91 percent was backed by financial sponsors, both on a fair value basis. Approximately 99 percent had one or more financial covenants on a cost basis. Covenant quality is another key point of differentiation from the upper middle market, as substantially all of our deals have at least one covenant compared to larger deals, which are generally without covenants. The average funded position was $13.1 million. The median EBITDA was approximately $48 million. The weighted average yield at cost of our direct origination portfolio was 11 percent on average for the December quarter, down from 11.6 percent for the September quarter. The decline in the yield was primarily due to the decline in base rates. At the end of December, the weighted average spread on the directly originated corporate lending portfolio was 578 basis points, up one basis point compared to the end of September. Regarding credit quality, we believe the overall credit quality of MFIC's direct origination portfolio remains stable. We are not observing any signs of general credit weakness. Our portfolio companies continue to show good financial performance as evidenced by continued positive revenue and EBITDA growth. The financial sponsors and management teams of our borrowers have been effectively managing growth and liquidity. In a handful of more challenged situations, we are seeing good financial sponsor support. We have seen a slight decrease in amendment requests related to covenants or liquidity. We saw an improvement in the weighted average interest coverage ratio, which is primarily attributable to the decline in base rates and the origination of new investments with higher interest coverage ratios. At the end of December, the weighted average interest coverage ratio is 2.1 times, up from 1.9 times last quarter. At the end of December, the weighted average net leverage for the direct origination portfolio increased slightly to 5.0 times, up from 5.43 times last quarter. We believe the stable level of revolver utilization we are seeing from our portfolio companies is an additional sign of the health of our portfolio. At the end of December, the percentage of our leverage lending revolver commitments that were drawn was essentially unchanged quarter over quarter. We believe a steady revolver utilization rate is an indicator of financial stability. Our underwriting on mid-cap source loans has proven to be sound. Based on data since mid-2016, which is the approximate date upon which we began utilizing our co-investment order, our annualized net realized and unrealized loss rate is around five basis points on loans sourced by mid-cap financial. We think this performance data shows how well the strategy is performed. The amount of investments on non-accrual status decreased on both a cost and fair value basis compared to the prior quarter. At the end of December, investments on non-accrual were 1.3 percent of the portfolio at fair value, down from 1.8 percent last quarter. During the December quarter, we exited one position that was on non-accrual status, which we acquired from the CEFs, and we placed one legacy second leading position on non-accrual status. MFIC's pick income remains relatively low, representing approximately 5.7 percent of total investment income for the quarter and 4 percent for the full year. In addition, we are closely reviewing our portfolio for any potential impacts from tariffs or other changes to government policies. We are generally underweight businesses that rely on imports and exports to and from the targeted countries and thus believe the impact will be limited should tariffs be put in place. We supplement our underwriting process in response to the past and potential tariffs as well as other new risks that may emerge. With that, I will now turn the call over to Greg to discuss our financial results in detail.
Thank you, Ted, and good morning, everyone. Starting with our operating results, total investment income for December was approximately $82.2 million flat compared to the prior quarter as a sequential increase in interest income was offset by a decline in fee income. The sequential increase in interest income was driven by a full quarter impact from the increase in prepayment income, higher average leverage partially offset by the impact of declining rates. The weighted average yield at cost on our directly originated portfolio was 11 percent for December, down from 11.6 percent last quarter due primarily to lower base rates. Dividend income was flat quarter over quarter. Net expenses for the quarter were $45.1 million, an increase of $1.1 million compared to the prior quarter driven by higher management and incentive fees partially offset by a decline in interest expense and other GNA. The fixed management fee for the quarter was approximately $6.2 million compared to $4.4 million in the December quarter. As a reminder, our base fee is 1.75 percent on net assets calculated as of the beginning of the quarter. The increase in net assets from the merger did not impact the management fee in the September quarter, but resulted in a higher management fee in the December quarter. MFIC's incentive fee is 17.5 percent. It is subject to a total return hurdle with a rolling 12-quarter look back. Given the total return feature and the net loss incurred during the look back period, MFIC's incentive fee for the December quarter was $5.3 million, or 12.6 percent of pre-incentive fee income. Interest expense declined due to lower base rates, partially offset by higher leverage during the quarter. For the December quarter, net investment income was 40 cents per share, resulting in a full year net investment income per share of $1.71. For the December quarter, gap EPS, or net income, per share was 26 cents, resulting in a full year gap EPS per share of $1.27. For the December quarter, in the full year, annualized return on equity based on net investment income was 10.5 percent and 12 and 11.2 percent respectively. The December quarter, the full and full year annualized return on equity based net income was 6.8 percent and 8.3 percent respectively. Results for the quarter include a net loss of approximately $13 million, or 14 cents
per share.
Approximately 60 percent of that net loss was from positions that were on non-acquire at the beginning of the quarter. We ended the year with net leverage of 1.16 times. We are operating below our target of around 1.4 times, given the deleveraging impact of the equity issued in July in connection with MFIC's mergers with the closed end funds. As Tanner and Ted mentioned, we intend to prudently increase leverage over the coming quarters, and we see no impediment to do so. At the end of December, our portfolio had a fair value of 3 billion. We had approximately 1.75 billion in debt and total assets were 1.4 billion, or $14.98 per share. Shifting to our capitalization, given the attractive nature of term based financing in the CLL market, the composition of our corporate portfolio and leveraging mid-cap financials, CLO success and expertise, we expect CLOs to be an important source of debt financing for MFIC going forward. In late December, MFIC priced a $529 million CLO, our second unbalanced CLO. It closed earlier this week. We sold the single A tranche, adding approximately $400 million of low cost secure debt at a splendid cost of 161 basis points spread. The spreads on middle market CLOs, tranches have tightened considerably over the past year due to strong investor interest. The spread on the senior AAA in the second CLO was 148 basis points compared to 248 basis points in our inaugural CLO, which we closed in November of 23. A tightening of 92 basis points. We believe this was amongst one of the tightest levels achieved in the middle market CLO, reflecting the high quality of the underlying loans. CLO has a reinvestment period through April 2029 and is not mature until January 2037. Proceeds from the CLO are effectively being used to repay $359 million of unsecured notes, which come due next week with the remaining balance used to pay down our credit facility. This concludes our remarks. Operator, please open all the questions.
Absolutely. At this time, if you would like to ask a question, please press the star and one keys on your telephone keypad. Keep in mind, you may remove yourself from the question queue at any time by pressing star and two. Take our first question from Phinny and O'Shea with Wells Fargo Securities. Please go ahead. Your line is open.
Hey, everyone. Good morning. Tanner, appreciate the comments. The post quarter insurance recovery for Merck's. Can you talk about any impact there? Or if that was a full recovery of what you have valued or if there's any earnings headwind, if that came in short. Thanks.
Yeah, Phin, thanks. The recoveries are approximately at our mark, so we're very happy with the results.
And does that imply like a more expedited wind down or return of capital there as well?
Well, yes. I mean, if you think we do have three planes that we have insurance recoveries on. As Tanner mentioned, the court proceedings were done in London. And so we do expect resolution of those claims this year.
OK, it's helpful. I guess like Merck's franchise wide, like, what are you feeling nowadays for the, you know, eventual exit? Maybe this year or more likely a next year thing.
Yeah, we I mean, I think as Tanner mentioned, we have some good line of sight for the sale of a significant amount of the portfolio that Merck's has. And we'll be reporting, you know, when we are able to do so with signed contracts.
OK, it's all for me. Thanks so much.
We'll take our next question from Mark Hughes with Truist. Please go ahead. Your line is open.
Yeah, thanks. Good morning. If things calm down in Russia and the Ukraine, would that be an opportunity for better recoveries or is that already locked in? Now, the
recoveries are locked in there. They're somewhat, you know, this is insurance based. So it's essentially what the insurers are willing to resolve the claims for. It's been very positive because the claims that we settled were pre the the final consultation of the court hearing. So it was more the momentum trying some of the insurers to get out front of on, you know, the ultimate conclusion by the courts, which you think will be positive on an insurance basis.
Yeah, to emphasize the resolution of the claims are now inextricably linked to the insurance process unrelated to what's happening on the ground.
Yeah. OK. Talked about an increase in spreads in the quarter and then leverage was a little bit lower. How much of that was mixed or was there some market movement that contributed to that?
Yeah, sure. Thanks. Thanks, Mark. And we tried to capture the nuance in the prepared remarks. We are still seeing spread compression, as we noted, not as significant or pronounced as maybe in other parts of the brother syndicated market or upper middle market, but notwithstanding still some spread compression and new deployments are at lower spreads than what our average book is run writing at right now. The the relative increase quarter over quarter had more to do as we tried to call out in our prepared remarks with the over waiting to existing portfolio companies. And so we don't we did not intend for this to to imply that spreads are widening, but rather just the power of incumbency and what we're able to drive with our existing borrowers, where the friction costs are such that we typically do better when we're redeploying into existing portfolio companies versus new kind of credit creation opportunities, which continue to be at at tight spreads relative to the rest of our book.
Thanks for that detail. How much more in your book is there to refi? Do you think the kind of investment into existing borrowers, the current spread? How much more do you anticipate might just be a natural consequence of this recent spread compression?
Yeah, I think it's tough to estimate. You know, you can look at you can look at, you know, you can look at what our average spread is at five seventy eight and you can see where the market is deploying at five hundred or so or five twenty five on average. You know, obviously in our particular quarter, as I already alluded to, we were a little bit higher that on account of reinvesting into current portfolio companies. But notwithstanding, you know, I would I would answer your question with that will have a lot to do with part of part of spreads going there is that. M&A has been relatively muted, you know, the bid ask spread for financial sponsors on account of a higher cost of capital has made it harder to get deals done. And as a result, the level of repricing and the level of repayment is a function of that as well. So it's tough to estimate. And with caveat that, you know, to the extent that we saw significant new credit creation opportunities, i.e. pick up in M&A, you could see some stabilization in yields and even even widening in certain cases, because the market on average is still grappling with a little bit of a technical overhang where there's more capital than there are new credit creation opportunities. And that's one of the reasons you've seen spreads go as tight as they have. And that's that's true across across all markets.
Yeah, then pick income up a little bit compared to earlier in the year, I assume maybe that's part of the merger. Where should that trend as we progress through 2025?
Yeah, so thanks, Mark. The you know, in terms of pick income, I think when you look at our overall portfolio, we continue to be comfortable with where the performance is, by and large. You know, we've seen interest rates come down over the last few quarters. You know, that should help. You know, I don't think anyone's forecasting kind of lower interest, even lower interest rates going forward. But that'll be one component to it. And then, you know, obviously, you know, the performance of the underlying borrowers, which, you know, as as with everyone else in the street, we have a handful of names that we watch very closely. But as we said in the prepared remarks, overall, the credit for the credit quality does remain stable.
Thank you. We'll take our next question from Sean Paul Adams with Raymond James. Please go ahead. Your line is open.
Yes, good morning. I did see non-accruals did take a dip for the quarter. Is it correct? There's only four non-accruals remaining from the legacy CEF portfolio on the books. And what's the status of the existing non-accrual perspective resolutions? Thank you.
Yeah, sure. I'll kind of hit that in reverse. So the positions on non-accrual, without going into too much detail, there were a number of restructuring transactions that occurred in the fourth quarter or, you know, into into the current quarter, which have put those in a more stable place. And so we'll be, you know, watching those going forward. Obviously, we we have from a portfolio standpoint, you know, a monitoring process around what's on a non-accrual, you know, what's on a watch list, et cetera. And in terms of the kind of details of non-accrual, page 11 in the earnings supplement, you know, lays out, you know, all of the names that and where they came from. And so, yeah, there are four names on non-accrual from the mergers.
Got it. Thank you. I appreciate it.
We'll take our next question from Matthew Hurwit with Jefferies. Please go ahead. Your line is open.
Morning, everyone. Hope you're well. Just following on the non-accrual conversation, can you give an update on Naviga and Renovo? Just what might be happening for those companies recently? And then what led to Securis being added to the list this quarter? Thanks.
Yeah, so, I mean, both of the or I guess all three of those names, you know, are going through processes where lenders are collaborating and working together, you know, to try to maximize the recovery or, you know, where those ultimate recoveries do come out and what the right amount of debt is to be carried by the company going forward. And I think, you know, in terms of where we keep those on non-accrual and the addition of Securis, as well as the ultimate outcome there is going to be driven by these restructuring processes and, you know, underlying performance of the companies going forward.
Yeah, and I would just say also, you know, we talk a lot about, you know, all of these are from the vintage kind of prior to COVID and we talk a lot about, you know, what has the increase in interest rates and each of these companies had issues that have been exacerbated by the increase in interest rates and less cash flow to reinvest in the business. And it would be, you know, those types of names that have been impacted in the current environment and made worse by, you know, underlying idiosyncratic issues within the companies.
Okay, thanks. That's helpful. And then just on your current dividend, it's obviously well supported by earnings, but given interest rate headwinds and spread compression, how confident are you in the sustainability of the dividend going forward?
Yeah, we're very comfortable with it, you know, considering where our leverage profile is and our, you know, expected, you know, origination pace.
Okay, thanks very
much. We'll take our next question from Paul Johnson with KBW. Please go ahead. Your line is open.
Yeah, thanks. Thanks. Good morning. Thanks for coming. Thanks for taking my questions. In terms of just the stability in the credit metrics that, you know, the certain credit metrics that you're seeing, I was just wondering if you could expand on that a little bit in terms of what you're observing.
Yeah, sure. So, you know, one of the things that we've been pointing out for the last several quarters is revolver utilization. And, you know, that has been pretty stable, you know, quarter over quarter, which shows that, you know, from a, that the companies are able to grow, you know, without pulling on their, you know, working capital facilities and also just kind of manage overall working capital and produce positive cash flow. So, and then in terms of interest coverage ratio, you know, we noted that that has improved. I think part of that is a combination of interest rates, the reduction in interest rates, but then also a part of it is what we're seeing in terms of new opportunities and the leverage that's there out of the box. You know, our overall portfolio leverage did tick up a little bit, but that's, you know, primarily, that's a weighted average number that's based on, you know, a few positions. But if you look at it on an obliquor basis, overall, it's steady to down.
Yeah, just to emphasize that last part of what Ted said is we report that on a, you know, and to be consistent with how we reported historically, it's a composite and it's a weighted average. And so that dynamics there are, it can be influenced by some underperformers. And so our commentary and the nuance in our commentary had to do with the fact that, yes, we have seen some improvement on interest coverage. And then also when we look overall to borrowers or we look in quartiles, you know, consistent with the comments that we made in the prepared remarks, see a stability in underlying performance across the portfolio outside of some of the idiosyncratic names we've called out and mentioned in the supplement.
Thanks for that. That's helpful. And then just in terms of kind of the write downs this quarter, I understand there were some restructurings, so there's a few things going on. But was there anything in particular that was kind of driving the net depreciation this quarter? Was it in legacy assets or were there any, you know, particular investments that were kind of driving that?
Well, I think as we said in our remarks, you know, if you looked at it, you know, over 60% of the decline were in positions that were already -non-equal. Those are, you know, companies that, you know, both Ted and Tanner have addressed and that we're working through with the sponsors, restructurings of those and or sales of those businesses. So they're more, you know, the valuation is going to be more based upon enterprise value. So therefore you have more fluctuation, you know, quarter to quarter.
Got it. Okay. I missed that comment. And then last one for me in terms of the CLO financing, congrats on that. That's, you know, pretty attractive pricing. So do you expect, you know, that to change the unsecured funding mix at all going forward with, you know, more attractive, potentially more attractive spread pricing in the securitization market?
Yes, yes, we do. We, you know, I think it's credit to the portfolio that we've been building over time and leveraging off of, you know, our relationship with MidCab Financial. They have over, they have 12 CLOs out there. Now we have two. And if you, I think when you look at the BDC space, there's a convergence of not only unsecured kind of spreads and secured spreads. And so therefore the secured spreads are inside the unsecured. And we believe it's very favorable use of or source of capital for us going forward. But it's a credit. It's, if you look at the portfolio, it's a function of what we have, the type of borrowers we have and the strength of that portfolio.
Thank you.
It's all
for me.
And as a reminder, if you'd like to ask a question, please press the star and one keys on your telephone keypad. We'll take our next question from Melissa Weddle with JP Morgan. Please go ahead. Your line is open.
Thank you. Good morning. Most of my questions have already been asked and answered, but I wanted to follow up a little bit on just the volume of repayment activity or exit activity in 4Q. Just by virtue of your talking about getting to target leverage in the next few quarters, it sounds like you're anticipating that deployment over the upcoming quarters. But I'm just curious, were you surprised at all by some of the repayment activity that you saw in 4Q? It seemed like it might have been a little bit elevated, even though you are doing a lot of sort of recycling of capital from the sort of post merger period. I'd just like to understand how you think about that.
Yeah, sure. Thanks, Melissa. First of all, on the deployment side, if we target 10% plus or minus of the portfolio of new commitments every quarter, we'll be back to target leverage in the next few quarters. The last third and fourth quarter of last year, as you point out, were dragged down by the sales of the CEF. I think that was on target, so I'd say none of that was a surprise. We're almost done with the recycling of the capital from the CEF. Going forward, it will be really re-levering, will really be a function of the deployment, which we feel very comfortable with given MidCaps' recent track record, long-term track record, recent deployment, and what our pipeline looks like. Then it will be kind of back to what I would say normal course of repayments, and that should allow us to achieve our goals in terms of re-levering.
Okay, appreciate that. Then just one follow-up question. I want to make sure we're understanding the realized losses correctly. Just by going through some of the tables in the okay, it looks like most of those realized losses were exited pretty close to where you had those investments marked. I've been referring more to the larger positions that drove that in 4Q.
Yes, and it was also, yes, it was, we did exit those. They were also, you were moving from unrealized to realized, right? We were cleaning up the SOI, cleaning up. You kind of come into the end of the year, and that's kind of what we typically do, so you're correct in that analysis.
Okay, great. Thank you.
We'll take our next question from Casey Alexander with CompassPoint. Please go ahead. Your line is open.
Yes, good morning. I'm just curious, because the originations in the quarter were actually lower than your quarterly average for the year, as well as repayments. You've often talked about how MidCap has substantial origination capacity, and in the past, the reason that you didn't see more of it in the BDC was because the BDC was up against its leverage limits. It seems to me that given those previous statements, that the decision not to take up the total value of the portfolio was a conscious decision. Can you speak to that? You talked about higher spreads. What was it that kept you from increasing the size of the portfolio and moving up the leverage ratio this quarter?
Yes, sure. Thanks, Casey. I think there are a number of factors, but I think the most tangible in our estimation and how we very deliberately tried to run the book is when you look at that swath of origination, we quoted the all-in numbers from MidCap. The emphasis for us as a management team has been to stay true to that requisite level of granularity within the portfolio. And so you can see the number of names that we were deploying into was substantial, but the average deployment in a given name kind of lagged and or we chose not to run it up. And as we've said in the past, yes, it was lower in this quarter versus last quarter. That does not reflect a decision not to. There are some things that are won and lost and ebbs and flows in what happens and what doesn't happen. And we're very comfortable with the level of deployment, as Ted alluded to. We feel very comfortable about the ability to get back up to one four and are cognizant of wanting to build in the granularity. The number of obligors actually went down quarter over quarter as a result of the names that we were selling out of CEFs are on average lower position sizes. But we aspire as a lot of the larger BDCs and a function of the fact that we had 500 obligors across its business. Over time, we would like to get to that. Ideally, we're at 233 right now. Ideally, get to get to a 300 number and show a really, really diverse level. And then finally, the decision or whatever part of this that was a deliberate decision goes to not wanting to over index to any any one quarter. So take your comment, Casey. I think, objectively, this was a lower commit than than last quarter has a little bit to do with granularity, but overall very comfortable about the access to the origination and this not representing a deliberate decision on the part of management not to deploy.
Also, if I could only call it kind of. Just to jump in, because I think you know, the general theme is, you know, we we we are obviously targeting as interest rates have gone down or and maybe stabilized now, having continuing to not only cover the dividend, but have cushion to cover the dividend. As you know, we have a few tailwinds to that, which is levering up and the redeployment of marks. And then we have, you know, and we added another tailwind this quarter, which is we got cheaper financing, I think, than we projected. Obviously, we have some headwinds, which is the repricing, you know, most notably. And so when we sort of like target to make sure that we continue to have comfort level to cover the dividend and actually expand that, that's sort of that's sort of our timeline. And so when Tanner's talking about the choices that we're making, like, levering up is, you know, an important part of our strategy, meaning, like, at the at the end point, we want to be at the right levers level. But we also are, you know, have I don't know luxury is the right word, but we have some flexibility in terms of sort of choosing granularity, which loans we pick, how we carry things forward, you know, when we exit and not. And so we're taking advantage of that. So I think 10 is right. I don't think you should read into sort of exactly one, you know, one quarter, but you, you know, hopefully we'll read into, you know, hopefully the consistency with which we can lay out a story that continues to have room to cover the dividend and have some cushion and different letters.
That's my only question. Thank you.
And there are no further questions on the line at this time. We'll turn the program back to management for any closing comments.
Thank you, operator. Thank you, everyone, for listening to today's call on behalf of the entire team. We thank you for your time today. Please feel free to reach out to us if you have any other questions. Have a good day.
This does conclude today's program. Thank you for your participation and you may now.